Literature DB >> 894344

Prolonged vasospasm produced by the breakdown products of erythrocytes.

K Osaka.   

Abstract

The cause of cerebral vasospasm has been generally attributed to the vasoconstrictive substances released from platelets. The role of extravasated erythrocytes in vasospasm has never been well analyzed. To elucidate this point, the basilar arteries of cats were exposed and subjected to topical application of various blood fractions in their fresh state and after prolonged incubation for 1 to 7 days. Incubation was done to test stability of the vasoconstrictors. Severe vasospasm was induced by application of fresh and incubated fractions of lysed erythrocytes. Fresh, intact erythrocytes had no vasoactivity, but by incubation they lysed and gained vasoconstrictors. Vasospasm induced by lysed erythrocytes both in their fresh state and after prolonged incubation never relaxed, and tended to increase in severity during observation up to 24 hours. Fresh serum and platelet-rich plasma had vasoconstrictors, but they were lost after incubation. Apparently platelet-induced vasoconstriction is of short duration and contributes only to the early phase of vasospasm. Later, 12 to 24 hours after hemorrhage, iron pigments released by lysis of extravasated erythrocytes (oxyhemoglobin or methemoglobin) irritate the arterial wall and induce prolonged vasospasm. It is emphasized that the study of cerebral vasospasm should be focused on the role of the breakdown products of extravasated erythrocytes.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 894344     DOI: 10.3171/jns.1977.47.3.0403

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  24 in total

1.  Symptomatic cerebral vasospasm of unusually late onset after aneurysm rupture.

Authors:  K Ohno; H Masaoka; R Suzuki; S Monma; Y Matsushima
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

2.  The effect of immediate decompression on the optic nerve in retrobulbar hematoma.

Authors:  A I Göçer; F Ildan; S Haciyakupoğlu; M Tuna; H Bağdatoğlu; S Polat; E Cetinalp; K Aksoy
Journal:  Neurosurg Rev       Date:  1996       Impact factor: 3.042

3.  Effect of intracisternal thromboxane A2 analogue on cerebral artery permeability.

Authors:  M Zuccarello; T Sasaki; N F Kassell; M Yamashita
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

Review 4.  Cerebral artery myogenic reactivity: The next frontier in developing effective interventions for subarachnoid hemorrhage.

Authors:  Darcy Lidington; Jeffrey T Kroetsch; Steffen-Sebastian Bolz
Journal:  J Cereb Blood Flow Metab       Date:  2017-11-14       Impact factor: 6.200

5.  Investigation of the vasoconstrictor action of subarachnoid haemoglobin in the pig cerebral circulation in vivo.

Authors:  J V Byrne; T M Griffith; D H Edwards; T J Harrison; K R Johnston
Journal:  Br J Pharmacol       Date:  1989-07       Impact factor: 8.739

6.  Experimental cerebral vasospasm: resolution by iloprost.

Authors:  N Egemen; K Birler; N Avman; R K Türker
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

7.  An experimental study of acute subarachnoid haemorrhage in baboons: changes in cerebral blood volume, blood flow, electrical activity and water content.

Authors:  H Kuyama; A Ladds; N M Branston; M Nitta; L Symon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-04       Impact factor: 10.154

8.  Beta-blockade benefits patients following a subarachnoid haemorrhage.

Authors:  G Neil-Dwyer; P Walter; J M Cruickshank
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

9.  Cyclic GMP mediates neurogenic relaxation in the bovine retractor penis muscle.

Authors:  A Bowman; A H Drummond
Journal:  Br J Pharmacol       Date:  1984-04       Impact factor: 8.739

10.  Does the method of treatment of acutely ruptured intracranial aneurysms influence the incidence and duration of cerebral vasospasm and clinical outcome?

Authors:  A J P Goddard; P P J Raju; A Gholkar
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-06       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.